SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001521536-12-000282
Filing Date
2012-04-16
Accepted
2012-04-16 17:07:11
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 q1100440_10k-biozone.htm 10-K 1074929
2 q1100440_ex31-1.htm EX-31.1 17751
3 q1100440_ex32-1.htm EX-32.1 6954
10 GRAPHIC paritzhead.jpg GRAPHIC 25691
  Complete submission text file 0001521536-12-000282.txt   2811246

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bzne-20111231.xml EX-101.INS 280241
5 XBRL SCHEMA FILE bzne-20111231.xsd EX-101.SCH 11599
6 XBRL CALCULATION FILE bzne-20111231_cal.xml EX-101.CAL 31652
7 XBRL DEFINITION FILE bzne-20111231_def.xml EX-101.DEF 17492
8 XBRL LABEL FILE bzne-20111231_lab.xml EX-101.LAB 98873
9 XBRL PRESENTATION FILE bzne-20111231_pre.xml EX-101.PRE 73430
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-146182 | Film No.: 12761836
SIC: 2834 Pharmaceutical Preparations